Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

doi:10.1002/art.23147

Skip navigation

Results
This Paper

To show you the PDF, we need your affiliation

(Don't worry, you'll only have to do this once)

Affiliation:

Cancel

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

Valérie V Martinez, Pascal P Cohen, Christian C Pagnoux, Stéphane S Vinzio, Alfred A Mahr, Luc L Mouthon, Laurent L Sailler, Claire C Delaunay, Alain A Sadoun, Loïc L Guillevin and Arthritis Rheum 58(1):308-17 (2008) PMID 18163506

To evaluate at 9 months and 24 months the safety and efficacy of intravenous immunoglobulins (IVIGs) administered for 6 months to treat relapses of Wegener's granulomatosis (WG) or microscopic polyangiitis (MPA) occurring either under treatment or during the year following discontinuation of corticosteroids and/or immunosuppressants.

DOI: 10.1002/art.23147
Version: za2963e q8zaa q8zb0 q8zce q8zda q8ze0 q8zf8 q8zg7

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

paper

citation

Thanks for joining pubget!

Sign up for free.

Log in to Pubget.

Advanced search Close

Limits Clear all Close

To show you the PDF, we need your affiliation

Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.

paper

citation